Lusutrombopag (Mulpleta) for severe thrombocytopenia in patients with chronic liver disease undergoing an elective invasive procedure
Lusutrombopag is a new drug to treat one of the symptoms of long-term liver disease, where low numbers of blood cells called platelets lead to poor blood clotting. This can lead to uncontrolled bleeding during surgery or other procedures, which can lead to delay or cancellation of treatment. The drug increases the number of platelets to make important procedures safe to perform. Lusutrombopag is taken as a tablet once a day for up to seven days. Lusutrombopag may offer a new treatment for low platelet levels in patients with liver disease and may be an alternative to the use of donor platelet infusions.